Famotidine and Microscopic polyangiitis - a phase IV clinical study of FDA data

Summary:

Microscopic polyangiitis is reported as a side effect among people who take Famotidine (famotidine), especially for people who are female, 60+ old, also take Diprivan, and have Prostate cancer.

The phase IV clinical study analyzes which people have Microscopic polyangiitis when taking Famotidine. It is created by eHealthMe based on reports of 81,914 people who have side effects when taking Famotidine from the FDA, and is updated regularly.

What is Famotidine?

Famotidine has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 83,421 Famotidine users. Check the latest studies of Famotidine.

What is Microscopic polyangiitis?

Microscopic polyangiitis (inflammation involving multiple blood or lymph small-vessel) is found to be associated with 32 drugs and 103 conditions by eHealthMe. Check the latest studies of Microscopic polyangiitis.

On Jul, 27, 2026

81,914 people reported to have side effects when taking Famotidine.
Among them, 14 people (0.02%) have Microscopic polyangiitis.

Could Famotidine cause Microscopic polyangiitis?

Among these 14 people:

What is the gender of people who have Microscopic polyangiitis when taking Famotidine? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Microscopic polyangiitis when taking Famotidine? *

What are other drugs people take besides Famotidine? *

What are other side effects people have besides Microscopic polyangiitis? *

Glomerulonephritis Rapidly Progressive (a syndrome of the kidney that is characterized by a rapid loss of renal function): 7 people, 50.00%
Pulmonary Alveolar Haemorrhage (acute bleeding): 6 people, 42.86%
Hypotension (abnormally low blood pressure): 6 people, 42.86%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 5 people, 35.71%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 5 people, 35.71%
Anaemia (lack of blood): 3 people, 21.43%
Cardiac Failure: 2 people, 14.29%
Neck Pain: 2 people, 14.29%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 2 people, 14.29%
Pleural Effusion (water on the lungs): 2 people, 14.29%

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 50.00%
Prostate Cancer: 7 people, 50.00%
Seasonal Allergy (allergic condition due to certain season): 6 people, 42.86%
Enlarged Prostate: 6 people, 42.86%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 6 people, 42.86%
Eye Pain: 6 people, 42.86%
Alanine Aminotransferase Decreased: 4 people, 28.57%
Aspartate Aminotransferase Increased: 4 people, 28.57%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 28.57%
Hyperkalemia (damage to or disease of the kidney): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Famotidine and have Microscopic polyangiitis?

- Check whether Microscopic polyangiitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Famotidine:

Famotidine (83,421 reports)

Browse all side effects of Famotidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Microscopic polyangiitis:

Microscopic polyangiitis (32 drugs)

Browse all the conditions that are associated with Microscopic polyangiitis:

Microscopic polyangiitis (103 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on famotidine (the active ingredients of Famotidine) and Famotidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.